AI assistant
Fagron N.V. — Board/Management Information 2010
Nov 15, 2010
3949_iss_2010-11-12_e4eb481c-f757-418b-bfde-15ae36db3902.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Press release Press release ess release
Regulated information
Change of permanent representative of EnHold NV
Waregem (Belgium) / Rotterdam (Netherlands)1 , 12 November 2010 – EnHold NV, the entity with which Waterland Private Equity Fund IV CV participates in Arseus NV, has informed Arseus NV that the mandate of Socius BVBA, represented by Mr Marcel Colla, as the permanent representative of EnHold NV in the Arseus NV Board of Directors, will be terminated as from 13 November 2010. EnHold NV has informed Arseus NV that it will be appointing De Wilde J Management BVBA, represented by Mr Julien De Wilde, as the permanent representative of EnHold NV, on 13 November 2010. Therefore, De Wilde J Management BVBA, represented by Mr Julien De Wilde, will from that day be the permanent representative of EnHold NV, a member of the Arseus NV Board of Directors.
Robert Peek, Chairman of the Arseus NV Board of Directors: "In recent years, Arseus has concentrated on its internal organisation and acquisitions in Europe. With the acquisition of the American company Gallipot in May this year, Fagron has taken its first step as a global consolidator in the niche market of pharmaceutical compounding. Potential acquisition opportunities are currently being sought for Fagron in Scandinavia, Central and Eastern Europe, the United States, Canada and Latin America. The further expansion of Arseus' international activities requires a different combination of experiences on the Board of Directors. Mr De Wilde's management qualities and extensive international experience make him ideally suited to play an important part in the further international development of Arseus from the Board of Directors.
On behalf of the other members of the Board of Directors, I would like to thank Mr Marcel Colla for his involvement and constructive contribution to the work of the Board of Directors."
Julien De Wilde
Julien De Wilde, who was born in 1944, obtained an engineering degree from the Catholic University of Leuven, in Belgium. From 1969 onwards he held various managerial positions at Texaco, and in 1986 he was appointed as a member of the European Management Board of Texaco in New York. In 1988 he became head of the Recticel research and business development centre, before joining the Executive Committee of Alcatel-Bell a year later, where he was responsible for strategy and general services. From 1995 until 1998, Julien De Wilde was the CEO of Alcatel-Bell and from 1999 until 2002 Executive Vice-
page 1 of 2
1 This press release was sent out by Arseus NV and Arseus BV.
President and member of the Executive Committee of Alcatel in Paris, with responsibility for Europe, the Middle East, Latin America, India and Africa. He was CEO of the Bekaert Groep from 1 July 2002 until May 2006. Julien De Wilde is currently Chairman of the Board of Directors of Agfa Gevaert and Nyrstar, and a member of the Board of Directors at KBC Bank and Telenet.
Financial calendar
| 10 January 2011 | Trading update fourth quarter 2010 |
|---|---|
| 16 February 2011 | Annual results for 2010 |
| 8 April 2011 | Trading update first quarter 2011 |
| 8 July 2011 | Trading update second quarter 2011 |
| 5 August 2011 | First-half results for 2011 |
| 10 October 2011 | Trading update third quarter 2011 |
Results and trading updates will be published at 07:30 a.m.
Arseus Profile
Arseus is a multinational group of companies that supplies products, services and concepts to professionals and institutions in the healthcare sector in Europe and the US. Arseus is subdivided into four divisions and operates in the markets for pharmaceutical compounding for pharmacies, dental products, medical and surgical products, and medical IT-solutions.
The Belgian company Arseus NV is located in Waregem, and is listed on NYSE Euronext Brussels and NYSE Euronext Amsterdam. The operational activities of the Arseus group are driven by the Dutch company Arseus BV. The head office of Arseus BV is located in Rotterdam.
In the event of any discrepancy between the English translation and the original Dutch version of this press release, the latter shall prevail. the prevail.
For more information: Constantijn van Rietschoten Director Corporate Communications +31 88 33 11 222 (office) +31 6 536 91 585 (mobile) [email protected]
page 2 of 2
Arseus press release